packageAmbenonium

ambenonium

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Ambenonium is an acetylcholinesterase inhibitor that was used to treat myasthenia gravis. It has been withdrawn and is no longer in clinical use.

Summary written by glm-5.3-flash from Wikidata Q4064027 and the WHO ATC classification; not checked by a person.

name:ambenonium
ATC codes:N07AA30
DrugBank:DB01122
PubChem CID:2131
ChEBI:2627
Wikidata:Q4064027
formula:C28H42Cl2N4O2+2
molar mass:537.57 g/mol (PubChem CID 2131)
logP:5.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown